Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Randomized Trial Comparing Lenalidomide With Low Dose Dexamethasone Versus Lenalidomide in Second Line Multiple Myeloma
ClinicalTrials.gov study NCT01450215. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03190525. IPD Sharing: UNDECIDED. Countries: 2. Publications: 2.
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymp
ClinicalTrials.gov study NCT03017820. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy.
ClinicalTrials.gov study NCT04519476. IPD Sharing: NO. Countries: 1. Publications: 2.
Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))
ClinicalTrials.gov study NCT00111813. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Velcade, Melphalan, Prednisone And Thalidomide Versus Velcade, Melphalan, Prednisone in Multiple Myeloma Patients
ClinicalTrials.gov study NCT01063179. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Clinical Study to Evaluate the Safety and Efficacy of CAR-T in the Treatment of Multiple Myeloma
ClinicalTrials.gov study NCT06068400. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00065351. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00316940. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Maligna
ClinicalTrials.gov study NCT00861510. IPD Sharing: Not stated. Countries: 1. Publications: 3.
The Feasibility and Effects of Exercise on Patients Suffering From Multiple Myeloma
ClinicalTrials.gov study NCT04300335. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT04248244. IPD Sharing: NO. Countries: 1. Publications: 1.
Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00049374. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Haploidentical Bone Marrow Stem Cell Transplantation in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT02519114. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)
ClinicalTrials.gov study NCT00773747. IPD Sharing: YES. Countries: 0. Publications: 1.
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM
ClinicalTrials.gov study NCT04975997. IPD Sharing: YES. Countries: 31. Publications: 1.
Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT01718899. IPD Sharing: Not stated. Countries: 1. Publications: 1.
High-dose Chemotherapy+G-CSF in Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT05517213. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01549431. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT01955395. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.